EU watchdog reviewing adapted Pfizer vaccine targeting Omicron
CGTN
Share
Copied
The European Union's drug watchdog said Wednesday that it has begun a review of an adapted version of Pfizer/BioNTech's anti-COVID jab that reportedly better protects against specific variants of the virus, including Omicron.